Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

The Cystic Fibrosis Foundation Affirms Support of the Introduction of the PASTEUR Act

06/16/2021 | 03:39pm EDT

 

Today, the Cystic Fibrosis Foundation affirmed its support for the PASTEUR Act, a bipartisan proposal that, if passed, will support the development of new antibiotics and promote appropriate use of existing ones. The organization issued the following statement:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210616005948/en/

A shortage of effective antibiotics puts the world at risk for future pandemics. Globally, antimicrobial resistance (AMR) is a top public health concern that we can no longer ignore. Finding new ways to incentivize and reward companies that bring vital new antibiotics to market are necessary for a sustainable marketplace. (Graphic: Business Wire)

A shortage of effective antibiotics puts the world at risk for future pandemics. Globally, antimicrobial resistance (AMR) is a top public health concern that we can no longer ignore. Finding new ways to incentivize and reward companies that bring vital new antibiotics to market are necessary for a sustainable marketplace. (Graphic: Business Wire)

“New solutions are needed now to bring novel antibiotics into the hands of patients. The Cystic Fibrosis Foundation applauds Senators Bennet and Young in reintroducing the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act. If passed, the PASTEUR Act has the potential to spur vital investment into new antibiotics by addressing the economic disincentives that have long been associated with antibiotic development.

“Routine use of antibiotics in cystic fibrosis care is medically necessary but unfortunately, too many people with CF find themselves battling difficult-to treat infections where existing antibiotics are not effective. However, antibiotic resistance is not solely a CF problem—it’s a human problem that we can no longer ignore.

“People with CF need more antibiotic options as do all Americans. The Foundation is making significant investments into the research and development of new approaches to address infections, but more is needed. Congress must take swift action to pass the PASTEUR Act, invigorating a new era of antibiotic research and development that could bring novel treatments into the hands of patients who need them the most.”

For more information about the Foundation’s work in fighting antimicrobial resistance, visit cff.org.

About the Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis. The Foundation funds more CF research than any other organization, and nearly every CF drug available today was made possible because of Foundation support. Based in Bethesda, Md., the Foundation also supports and accredits a national care center network that has been recognized by the National Institutes of Health as a model of care for a chronic disease. The CF Foundation is a donor-supported nonprofit organization. For more information, visit cff.org.


© Business Wire 2021
Latest news "Companies"
01:05pROSEN, A LEADING LAW FIRM, Encourages Rocket Companies, Inc. Investors to Secure Counsel Before Important August 30 Deadline in Securities Class Action – RKT
GL
12:51pAHF : ‘Providence Journal' Rejects Ad Skewering CVS's PBM Abuse
BU
12:32pMTD FOR INCOME TAX : What landlords need to know
PU
12:32pMTD FOR INCOME TAX SELF ASSESSMENT : What accountants and clients need to do
PU
12:22pGLOBAL PARTNERS LP : Supports The Genesis Foundation with The Giving Pump
PU
12:06pAllianz cooperating as DOJ probes Structured Alpha Funds
RE
12:06pALLIANZ : cooperating as DOJ probes Structured Alpha Funds
RE
12:06pPRINCESS CRUISES : Successfully Completes First Voyage Following Extended Pause in Operations
PR
11:52aPM to interact with beneficiaries of Pradhan Mantri Garib Kalyan Anna Yojana in Gujarat on 3rd August
PU
11:52aBMW : Battle for the podium at the 24h Spa-Francorchamps comes to an early end for Walkenhorst Motorsport.
PU
Latest news "Companies"